395 related articles for article (PubMed ID: 31241993)
1. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through induction of Tollip and negative regulation of IRAK-1.
Watts BA; Tamayo E; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2019 Sep; 317(3):F705-F719. PubMed ID: 31241993
[TBL] [Abstract][Full Text] [Related]
2. Monophosphoryl lipid A induces protection against LPS in medullary thick ascending limb through a TLR4-TRIF-PI3K signaling pathway.
Watts BA; George T; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2017 Jul; 313(1):F103-F115. PubMed ID: 28356284
[TBL] [Abstract][Full Text] [Related]
3. Monophosphoryl lipid A prevents impairment of medullary thick ascending limb [Formula: see text] absorption and improves plasma [Formula: see text] concentration in septic mice.
Watts BA; George T; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2018 Sep; 315(3):F711-F725. PubMed ID: 29741098
[TBL] [Abstract][Full Text] [Related]
4. Monophosphoryl lipid A pretreatment suppresses sepsis- and LPS-induced proinflammatory cytokine production in the medullary thick ascending limb.
Watts BA; Tamayo E; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2020 Jul; 319(1):F8-F18. PubMed ID: 32421349
[TBL] [Abstract][Full Text] [Related]
5. Basolateral LPS inhibits NHE3 and HCOFormula absorption through TLR4/MyD88-dependent ERK activation in medullary thick ascending limb.
Watts BA; George T; Sherwood ER; Good DW
Am J Physiol Cell Physiol; 2011 Dec; 301(6):C1296-306. PubMed ID: 21881005
[TBL] [Abstract][Full Text] [Related]
6. Endothelial cell tolerance to lipopolysaccharide challenge is induced by monophosphoryl lipid A.
Stark RJ; Choi H; Koch SR; Fensterheim BA; Lamb FS; Sherwood ER
Clin Sci (Lond); 2016 Mar; 130(6):451-61. PubMed ID: 26669797
[TBL] [Abstract][Full Text] [Related]
7. Lumen LPS inhibits HCO3(-) absorption in the medullary thick ascending limb through TLR4-PI3K-Akt-mTOR-dependent inhibition of basolateral Na+/H+ exchange.
Watts BA; George T; Good DW
Am J Physiol Renal Physiol; 2013 Aug; 305(4):F451-62. PubMed ID: 23698118
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 2 is required for LPS-induced Toll-like receptor 4 signaling and inhibition of ion transport in renal thick ascending limb.
Good DW; George T; Watts BA
J Biol Chem; 2012 Jun; 287(24):20208-20. PubMed ID: 22523073
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 mediates inhibition of HCO(3)(-) absorption by bacterial lipoprotein in medullary thick ascending limb.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2010 Sep; 299(3):F536-44. PubMed ID: 20554644
[TBL] [Abstract][Full Text] [Related]
10. A two-hit mechanism for sepsis-induced impairment of renal tubule function.
Watts BA; George T; Sherwood ER; Good DW
Am J Physiol Renal Physiol; 2013 Apr; 304(7):F863-74. PubMed ID: 23324175
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
12. Procyanidin dimer B2-mediated IRAK-M induction negatively regulates TLR4 signaling in macrophages.
Sung NY; Yang MS; Song DS; Kim JK; Park JH; Song BS; Park SH; Lee JW; Park HJ; Kim JH; Byun EB; Byun EH
Biochem Biophys Res Commun; 2013 Aug; 438(1):122-8. PubMed ID: 23872113
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group box 1 inhibits HCO(3)(-) absorption in medullary thick ascending limb through a basolateral receptor for advanced glycation end products pathway.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2015 Oct; 309(8):F720-30. PubMed ID: 26180239
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of impaired NLRP3 inflammasome priming by monophosphoryl lipid A.
Embry CA; Franchi L; Nuñez G; Mitchell TC
Sci Signal; 2011 May; 4(171):ra28. PubMed ID: 21540455
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 dominance over Toll-like receptor 4 in stressful conditions for its detrimental role in the heart.
Bagchi AK; Akolkar G; Mandal S; Ayyappan P; Yang X; Singal PK
Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1238-H1247. PubMed ID: 28432060
[TBL] [Abstract][Full Text] [Related]
16. Selective activation of the p38 MAPK pathway by synthetic monophosphoryl lipid A.
Cekic C; Casella CR; Eaves CA; Matsuzawa A; Ichijo H; Mitchell TC
J Biol Chem; 2009 Nov; 284(46):31982-91. PubMed ID: 19759006
[TBL] [Abstract][Full Text] [Related]
17. Monophosphoryl lipid A inhibits the cytokine response of endothelial cells challenged with LPS.
Stark R; Choi H; Koch S; Lamb F; Sherwood E
Innate Immun; 2015 Aug; 21(6):565-74. PubMed ID: 25540284
[TBL] [Abstract][Full Text] [Related]
18. Lipopolysaccharide directly inhibits bicarbonate absorption by the renal outer medullary collecting duct.
Tsuruoka S; Purkerson JM; Schwartz GJ
Sci Rep; 2020 Nov; 10(1):20548. PubMed ID: 33239624
[TBL] [Abstract][Full Text] [Related]
19. Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes.
Good DW; George T; Watts BA
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F866-74. PubMed ID: 19625374
[TBL] [Abstract][Full Text] [Related]
20. The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4.
Mata-Haro V; Cekic C; Martin M; Chilton PM; Casella CR; Mitchell TC
Science; 2007 Jun; 316(5831):1628-32. PubMed ID: 17569868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
